Pre-transplant molecular international prognostic scoring system score reduction is not associated with improved outcomes in myelodysplastic syndromes
- DOI
- 10.1038/s41408-026-01586-9
- Published
- 2026-07-27
- Container
- Blood Cancer Journal
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41408-026-01586-9,
title = {Pre-transplant molecular international prognostic scoring system score reduction is not associated with improved outcomes in myelodysplastic syndromes},
author = {Masataka Sakashita and Junya Kanda and Keiichiro Hattori and Nobuhiro Hiramoto and Nobuhiro Kanemura and Senji Kasahara and Mitsumasa Watanabe and Satoshi Yoshihara and Michiko Ichii and Nobuo Sezaki and Masaaki Tsuji and Takeshi Maeda and Ko Sasaki and Toshiyuki Kitano and Yasuko Miyahara and Tadakazu Kondo and Mamiko Sakata-Yanagimoto and Akifumi Takaori-Kondo and Seishi Ogawa and Yasuhito Nannya},
year = {2026},
journal = {Blood Cancer Journal},
doi = {10.1038/s41408-026-01586-9},
url = {https://doi.org/10.1038/s41408-026-01586-9}
}RIS
TY - JOUR TI - Pre-transplant molecular international prognostic scoring system score reduction is not associated with improved outcomes in myelodysplastic syndromes AU - Masataka Sakashita AU - Junya Kanda AU - Keiichiro Hattori AU - Nobuhiro Hiramoto AU - Nobuhiro Kanemura AU - Senji Kasahara AU - Mitsumasa Watanabe AU - Satoshi Yoshihara AU - Michiko Ichii AU - Nobuo Sezaki AU - Masaaki Tsuji AU - Takeshi Maeda AU - Ko Sasaki AU - Toshiyuki Kitano AU - Yasuko Miyahara AU - Tadakazu Kondo AU - Mamiko Sakata-Yanagimoto AU - Akifumi Takaori-Kondo AU - Seishi Ogawa AU - Yasuhito Nannya PY - 2026 JO - Blood Cancer Journal DO - 10.1038/s41408-026-01586-9 UR - https://doi.org/10.1038/s41408-026-01586-9 ER -
APA
Sakashita, M., Kanda, J., Hattori, K., Hiramoto, N., Kanemura, N., Kasahara, S., Watanabe, M., Yoshihara, S., Ichii, M., Sezaki, N., Tsuji, M., Maeda, T., Sasaki, K., Kitano, T., Miyahara, Y., Kondo, T., Sakata-Yanagimoto, M., Takaori-Kondo, A., Ogawa, S., & Nannya, Y. (2026). Pre-transplant molecular international prognostic scoring system score reduction is not associated with improved outcomes in myelodysplastic syndromes. Blood Cancer Journal. https://doi.org/10.1038/s41408-026-01586-9
Source records
- crossref · retrieved 2026-09-26T06:28:10.265Z